Getting Its ACT Together: EXACT-Tx Raises NOK155m
Money Will Advance Norwegian Biotech’s ACT Platform
Executive Summary
EXACT-Tx will use funds from a NOK155m private placing to harness ultrasound in precision therapeutic targeting across a variety of indications and product classes.